• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

私人医疗保险的国家监管:处方药福利、实验性治疗与消费者保护。

State regulation of private health insurance: prescription drug benefits, experimental treatments, and consumer protection.

作者信息

Bolin Jane Nelson, Buchanan Robert J, Smith Scott R

机构信息

Department of Health Policy and Management, School of Rural Public Health, The Texas A&M University System Health Sciences Center, College Station, 77843-1266, USA.

出版信息

Am J Manag Care. 2002 Nov;8(11):977-85.

PMID:12437312
Abstract

This study analyzes the results of 2 surveys sent to state insurance commissioners that focused on policies regulating conventional health insurance and managed care organizations (MCOs) during 2000. Surveys were returned by 49 states and the District of Columbia. Several states have implemented regulations mandating prescription drug coverage. In addition, some states now require health insurers and MCOs to cover the medical care associated with experimental medications and treatments. Some states have also created laws allowing beneficiaries to sue their health insurer or MCO for damages caused by denial of care. These state policies provide a rich source of data for federal policy makers to analyze as they consider new patient protection legislation and amendments to the Employee Retirement Income Security Act.

摘要

本研究分析了发给州保险专员的两份调查问卷的结果,这两份问卷聚焦于2000年期间规范传统医疗保险和管理式医疗组织(MCO)的政策。49个州和哥伦比亚特区回复了问卷。几个州已实施要求提供处方药保险的规定。此外,一些州现在要求健康保险公司和管理式医疗组织涵盖与实验性药物和治疗相关的医疗护理。一些州还制定了法律,允许受益人起诉其健康保险公司或管理式医疗组织,要求赔偿因拒绝提供护理而造成的损失。这些州政策为联邦政策制定者在考虑新的患者保护立法和对《雇员退休收入保障法》的修订时提供了丰富的数据分析来源。

相似文献

1
State regulation of private health insurance: prescription drug benefits, experimental treatments, and consumer protection.私人医疗保险的国家监管:处方药福利、实验性治疗与消费者保护。
Am J Manag Care. 2002 Nov;8(11):977-85.
2
Recent developments in health insurance, life insurance, and disability insurance case law.健康保险、人寿保险和残疾保险判例法的最新发展。
Tort Trial Insur Pract Law J. 2008 Spring;43(3):473-517.
3
Redefining private insurance in a changing market structure.在不断变化的市场结构中重新定义私人保险。
Baxter Health Policy Rev. 1996;2:33-62.
4
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划;医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
5
Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.医疗保险D部分:成就与持续挑战。医疗保险D部分对马萨诸塞州医疗项目及受益人的影响。
Issue Brief (Mass Health Policy Forum). 2007 May 30(32):1-32.
6
Implementing the Affordable Care Act: state action on the 2014 market reforms.实施《平价医疗法案》:2014年市场改革中的州行动。
Issue Brief (Commonw Fund). 2013 Feb;8:1-14.
7
Recent developments in employee benefits law.
Tort Trial Insur Pract Law J. 2005 Winter;40(2):345-68.
8
Final regulations for health coverage portability for group health plans and group health insurance issuers under HIPAA Titles I & IV. Final regulation.《健康保险流通与责任法案》第一和四章下团体健康计划及团体健康保险发行人健康保险可携性的最终规定。最终规定。
Fed Regist. 2004 Dec 30;69(250):78719-99.
9
Managed care liability.管理式医疗责任
Physician Exec. 1999 Mar-Apr;25(2):77-9.
10
Finance issue brief: Consumer grievance procedures: internal and independent appeals: year end report-2003.
Issue Brief Health Policy Track Serv. 2003 Dec 31:1-43.